Multiparametric Monitoring of Disease Progression in Contemporary Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy Initiating Tafamidis Treatment.
Svenja NeyRoman Johannes GertzLenhard PennigRichard J NiesUdo HoltickLinus A VölkerGilbert WunderlichKatharina SeutheChristopher HohmannClemens MetzeClaas Philip NähleJennifer von SteinMonique WöstenHenrik Ten FreyhausRoman PfisterPublished in: Journal of clinical medicine (2024)
We provide first frequency estimates of the markers of disease progression according to a recent expert consensus statement, which might help refine the multiparametric monitoring concept in patients with ATTR-CM.